Jyong Biotech Ltd. Ordinary Shares (NASDAQ: MENS) last traded at $2.18, up 0.93% on the session. The quote above updates while this page is open; the figures below are drawn from Jyong Biotech Ltd. Ordinary Shares’s own filings and are restated only when a new one is published.
Jyong Biotech Ltd. Ordinary Shares (MENS) company overview
Jyong Biotech Ltd. Ordinary Shares trades on NASDAQ under the ticker MENS. Its market capitalisation is $165.74 million.
MENS valuation
Valuation measures for Jyong Biotech Ltd. Ordinary Shares, derived from the latest quote and its most recent SEC filing.
Market cap
$165.74M
Beta
2.03
MENS financials
Trailing-twelve-month figures tagged in Jyong Biotech Ltd. Ordinary Shares's XBRL filings with the SEC.
Net income (TTM)
-$4.67M
EPS (TTM)
-$0.0600
MENS trading statistics
Range and volume for MENS over the past 52 weeks.
52-week high
$67.00
52-week low
$1.43
Volume
17.1K
Average volume
88.3K
Previous close
$2.16
Jyong Biotech Ltd. Ordinary Shares (MENS) FAQs
What is the MENS stock price today?
Jyong Biotech Ltd. Ordinary Shares (MENS) last traded at $2.18, up 0.93% on the session. FurlPay quotes MENS from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is MENS listed on?
Jyong Biotech Ltd. Ordinary Shares is listed on NASDAQ under the ticker symbol MENS.
What is Jyong Biotech Ltd. Ordinary Shares's market cap?
Jyong Biotech Ltd. Ordinary Shares has a market capitalisation of $165.74 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is MENS's 52-week range?
Over the past 52 weeks MENS has traded between $1.43 and $67.00.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001954488), period ending 2025-12-31.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.